Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2006

Perner S, Demichelis F, Beroukhim R, Schmidt FH, Mosquera J-, Setlur S, et al. TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. Cancer Res. 2006;66(17):8337-41.

Magro CM, Seilstad KH, Porcu P, Morrison CD. Primary CD20+CD10+CD8+ T-cell lymphoma of the skin with IgH and TCR beta gene rearrangement. Am J Clin Pathol. 2006;126(1):14-22.

Wendel H-, Malina A, Zhao Z, Zender L, Kogan SC, Cordon-Cardo C, et al. Determinants of sensitivity and resistance to rapamycin-chemotherapy drug combinations in vivo. Cancer Res. 2006;66(15):7639-46.

de Reyniès A, Geromin D, Cayuela J-, Petel F, Dessen P, Sigaux F, et al. Comparison of the latest commercial short and long oligonucleotide microarray technologies. BMC Genomics. 2006;7:51.

Linger J, Tyler JK. Global replication-independent histone H4 exchange in budding yeast. Eukaryot Cell. 2006;5(10):1780-7.

Febbo PG, Thorner A, Rubin MA, Loda M, Kantoff PW, Oh WK, et al. Application of oligonucleotide microarrays to assess the biological effects of neoadjuvant imatinib mesylate treatment for localized prostate cancer. Clin Cancer Res. 2006;12(1):152-8.

Zhou P. REGgamma: a shortcut to destruction. Cell. 2006;124(2):256-7.

Oh WK, Hayes J, Evan C, Manola J, George DJ, Waldron H, et al. Development of an integrated prostate cancer research information system. Clin Genitourin Cancer. 2006;5(1):61-6.

A Crowson N, Magro CM, Mihm MC. Malignant adnexal neoplasms. Mod Pathol. 2006;19 Suppl 2:S93-S126.

Ogino S, Odze RD, Kawasaki T, Brahmandam M, Kirkner GJ, Laird PW, et al. Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma. Am J Surg Pathol. 2006;30(9):1175-83.